Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 5 studies | 41% ± 20% | |
| astrocyte | 4 studies | 24% ± 3% | |
| glutamatergic neuron | 4 studies | 49% ± 20% | |
| interneuron | 4 studies | 38% ± 21% | |
| hepatocyte | 3 studies | 47% ± 10% | |
| oligodendrocyte precursor cell | 3 studies | 25% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 45% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 1508.69 | 226 / 226 | 85% | 20.77 | 346 / 406 |
| thymus | 99% | 225.59 | 644 / 653 | 86% | 3.65 | 522 / 605 |
| brain | 85% | 437.45 | 2253 / 2642 | 90% | 3.07 | 635 / 705 |
| prostate | 91% | 200.42 | 223 / 245 | 64% | 1.29 | 322 / 502 |
| ovary | 97% | 186.90 | 174 / 180 | 50% | 1.00 | 215 / 430 |
| bladder | 90% | 197.43 | 19 / 21 | 41% | 1.64 | 207 / 504 |
| uterus | 98% | 197.85 | 166 / 170 | 29% | 0.70 | 133 / 459 |
| breast | 82% | 158.95 | 375 / 459 | 33% | 0.73 | 369 / 1118 |
| lung | 58% | 74.19 | 338 / 578 | 55% | 1.35 | 632 / 1155 |
| esophagus | 67% | 100.99 | 972 / 1445 | 42% | 1.27 | 77 / 183 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.95 | 1 / 1 |
| skin | 72% | 543.18 | 1305 / 1809 | 27% | 0.58 | 128 / 472 |
| blood vessel | 98% | 381.68 | 1307 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 76% | 141.20 | 735 / 966 | 11% | 0.21 | 58 / 527 |
| adrenal gland | 31% | 27.52 | 80 / 258 | 53% | 2.00 | 123 / 230 |
| adipose | 83% | 187.55 | 1000 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 46% | 81.07 | 164 / 359 | 26% | 0.45 | 74 / 286 |
| lymph node | 0% | 0 | 0 / 0 | 62% | 1.89 | 18 / 29 |
| muscle | 58% | 70.76 | 464 / 803 | 0% | 0 | 0 / 0 |
| pancreas | 27% | 23.08 | 87 / 328 | 21% | 0.54 | 37 / 178 |
| kidney | 17% | 15.27 | 15 / 89 | 29% | 0.54 | 262 / 901 |
| spleen | 44% | 40.81 | 105 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 38% | 1.22 | 17 / 45 |
| heart | 31% | 27.74 | 268 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 23% | 0.37 | 18 / 80 |
| peripheral blood | 18% | 25.12 | 168 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0071401 | Biological process | cellular response to triglyceride |
| GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
| GO_0006507 | Biological process | GPI anchor release |
| GO_0071467 | Biological process | cellular response to pH |
| GO_0051044 | Biological process | positive regulation of membrane protein ectodomain proteolysis |
| GO_0032869 | Biological process | cellular response to insulin stimulus |
| GO_0010897 | Biological process | negative regulation of triglyceride catabolic process |
| GO_0009749 | Biological process | response to glucose |
| GO_0070633 | Biological process | transepithelial transport |
| GO_0010983 | Biological process | positive regulation of high-density lipoprotein particle clearance |
| GO_0002042 | Biological process | cell migration involved in sprouting angiogenesis |
| GO_0010595 | Biological process | positive regulation of endothelial cell migration |
| GO_0002062 | Biological process | chondrocyte differentiation |
| GO_0010867 | Biological process | positive regulation of triglyceride biosynthetic process |
| GO_0071277 | Biological process | cellular response to calcium ion |
| GO_0035774 | Biological process | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO_0010694 | Biological process | positive regulation of alkaline phosphatase activity |
| GO_0008286 | Biological process | insulin receptor signaling pathway |
| GO_0071397 | Biological process | cellular response to cholesterol |
| GO_0097241 | Biological process | hematopoietic stem cell migration to bone marrow |
| GO_0035701 | Biological process | hematopoietic stem cell migration |
| GO_0046470 | Biological process | phosphatidylcholine metabolic process |
| GO_0010907 | Biological process | positive regulation of glucose metabolic process |
| GO_0051047 | Biological process | positive regulation of secretion |
| GO_0001503 | Biological process | ossification |
| GO_1900076 | Biological process | regulation of cellular response to insulin stimulus |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_0002430 | Biological process | complement receptor mediated signaling pathway |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005765 | Cellular component | lysosomal membrane |
| GO_0004621 | Molecular function | glycosylphosphatidylinositol phospholipase D activity |
| GO_0004630 | Molecular function | phospholipase D activity |
| GO_0017080 | Molecular function | sodium channel regulator activity |
| Gene name | GPLD1 |
| Protein name | Phosphatidylinositol-glycan-specific phospholipase D (PI-G PLD) (EC 3.1.4.50) (Glycoprotein phospholipase D) (Glycosyl-phosphatidylinositol-specific phospholipase D) (GPI-PLD) (GPI-specific phospholipase D) |
| Synonyms | PIGPLD1 |
| Description | FUNCTION: This protein hydrolyzes the inositol phosphate linkage in proteins anchored by phosphatidylinositol glycans (GPI-anchor) thus releasing these proteins from the membrane. |
| Accessions | ENST00000230036.2 [P80108-1] P80108 |
